A neuromuscular medicine expert and leader in the field of amyotrophic lateral sclerosis (ALS), Jinsy A. Andrews, MD, joins ...
Novartis may have signed off on the second-largest pharma acquisition of 2025 so far, but as the company’s CEO sees it—it’s never about the price tag. | Novartis may have signed off on the second ...
This year marks Hines’s fifth consecutive season dedicating his cleats to MDA’s cause. He continues to champion the mission through his public service announcement for MDA and fundraising initiatives, ...
The article 🌱 Patch AM: Dallas families struggle to find care for neuromuscular diseases appeared first on Dallas Patch. Hi ...
Based on the final count by Computershare Trust Company, N.A., the depositary for the Tender Offer (the “Depositary”), a total of 17,712,262 shares of Keros common stock were validly tendered and not ...
The Pittsburgh Jewish Chronicle on MSN
In world first, Israeli scientists use RNA-based gene therapy to stop ALS deterioration
By adding a microRNA molecule to ALS models, Tel Aviv University, Ben-Gurion University and Weizmann Institute researchers ...
In his role on the SAB of NewcelX, Prof. Shefner will provide strategic guidance on the Company's programs in ALS, including ...
NewcelX ( ($NCEL) ) has shared an announcement. On November 17, 2025, NewcelX Ltd. announced the appointment of Prof. Jeremy Shefner, MD, PhD, to ...
Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, presented Phase 1 data for its lead candidate, MF-300, at the ...
Alice Wong, a visionary leader in disability justice and culture, died from an infection on November 14 in San Francisco. She ...
Whether you’re experiencing memory issues, anxiety, or just don’t feel like yourself, knowing when to see a specialist can ...
The Colorado Therapeutic Riding Center says demand for equine-assisted therapy is the highest it’s been in the nonprofit’s 40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results